Acute Lymphoblastic Leukemia News and Research

RSS
Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells, the cells in the body that normally fight infections. There are two main types of white blood cells-lymphoid cells and myeloid cells. ALL affects lymphoid cells.
Moffitt researchers shed light on how CAR T cells function mechanistically

Moffitt researchers shed light on how CAR T cells function mechanistically

Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children

Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children

Study: Prolonged presence of precursor cells in thymus may give rise to leukemia

Study: Prolonged presence of precursor cells in thymus may give rise to leukemia

Researchers identify multiple new subtypes of most common childhood cancer

Researchers identify multiple new subtypes of most common childhood cancer

Research reviews role of protein tyrosine phosphatase in molecular biology

Research reviews role of protein tyrosine phosphatase in molecular biology

CHLA researcher reveals how leukemia burrows within the bone marrow

CHLA researcher reveals how leukemia burrows within the bone marrow

Genetic marker, predictor of early relapse in common childhood cancer discovered

Genetic marker, predictor of early relapse in common childhood cancer discovered

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

New strategies may improve performance of CAR-T cell therapy in treating cancer

New strategies may improve performance of CAR-T cell therapy in treating cancer

Research highlights ability of Bio-Rad's ddPCR in quantifying minimal residual disease

Research highlights ability of Bio-Rad's ddPCR in quantifying minimal residual disease

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

St. Jude Hospital announces availability of largest collections of leukemia samples

St. Jude Hospital announces availability of largest collections of leukemia samples

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth